88 related articles for article (PubMed ID: 20347868)
1. The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts.
Pongsai P; Atamasirikul K; Sungkanuparph S
J Infect; 2010 Jun; 60(6):474-7. PubMed ID: 20347868
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.
McKenney J; Bauman S; Neary B; Detels R; French A; Margolick J; Doherty B; Klausner JD
Clin Infect Dis; 2015 Mar; 60(6):959-65. PubMed ID: 25422390
[TBL] [Abstract][Full Text] [Related]
3. CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.
Ford N; Shubber Z; Jarvis JN; Chiller T; Greene G; Migone C; Vitoria M; Doherty M; Meintjes G
Clin Infect Dis; 2018 Mar; 66(suppl_2):S152-S159. PubMed ID: 29514236
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of cryptococcosis among HIV-infected patients in Yaounde, Cameroon.
Dzoyem JP; Kechia FA; Ngaba GP; Lunga PK; Lohoue PJ
Afr Health Sci; 2012 Jun; 12(2):129-33. PubMed ID: 23056017
[TBL] [Abstract][Full Text] [Related]
5. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis.
Rajasingham R; Govender NP; Jordan A; Loyse A; Shroufi A; Denning DW; Meya DB; Chiller TM; Boulware DR
Lancet Infect Dis; 2022 Dec; 22(12):1748-1755. PubMed ID: 36049486
[TBL] [Abstract][Full Text] [Related]
6. Asymptomatic cryptococcal antigenemia in HIV-infected patients: a review of recent studies.
Xu XL; Zhao T; Harypursat V; Lu YQ; Li Y; Chen YK
Chin Med J (Engl); 2020 Dec; 133(23):2859-2866. PubMed ID: 33273336
[TBL] [Abstract][Full Text] [Related]
7. Cryptococcal meningitis manifesting as a large abdominal cyst in a HIV-infected patient with a CD4 count greater than 400 cells/mm(3).
Crum-Cianflone N; Truett A; R Wallace M
AIDS Patient Care STDS; 2008 May; 22(5):359-63. PubMed ID: 18373418
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive risk factor predictions for 3-year survival among HIV-associated and disseminated cryptococcosis involving lungs and central nervous system.
Wu L; Fu X; Pütz B; Zhang R; Liu L; Song W; Weng L; Shao Y; Zheng Z; Xun J; Han X; Wang T; Shen Y; Lu H; Müller-Myhsok B; Chen J
Infection; 2024 Apr; ():. PubMed ID: 38613657
[TBL] [Abstract][Full Text] [Related]
9. Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care.
Rajasingham R; Meya DB; Boulware DR
J Acquir Immune Defic Syndr; 2012 Apr; 59(5):e85-91. PubMed ID: 22410867
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.
Meya DB; Manabe YC; Castelnuovo B; Cook BA; Elbireer AM; Kambugu A; Kamya MR; Bohjanen PR; Boulware DR
Clin Infect Dis; 2010 Aug; 51(4):448-55. PubMed ID: 20597693
[TBL] [Abstract][Full Text] [Related]
11. Short Communication: Low seroprevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in Ghana.
Mamoojee Y; Shakoor S; Gorton RL; Sarfo S; Appiah LT; Norman B; Balakrishnan I; Phillips R; Chadwick D
Trop Med Int Health; 2011 Jan; 16(1):53-6. PubMed ID: 21371208
[TBL] [Abstract][Full Text] [Related]
12. The impact of routine cryptococcal antigen screening on survival among HIV-infected individuals with advanced immunosuppression in Kenya.
Meyer AC; Kendi CK; Penner JA; Odhiambo N; Otieno B; Omondi E; Opiyo E; Bukusi EA; Cohen CR
Trop Med Int Health; 2013 Apr; 18(4):495-503. PubMed ID: 23368667
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and correlates of cryptococcal antigen positivity among AIDS patients--United States, 1986-2012.
McKenney J; Smith RM; Chiller TM; Detels R; French A; Margolick J; Klausner JD;
MMWR Morb Mortal Wkly Rep; 2014 Jul; 63(27):585-7. PubMed ID: 25006824
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program--Vietnam.
Smith RM; Nguyen TA; Ha HT; Thang PH; Thuy C; Lien TX; Bui HT; Le TH; Struminger B; McConnell MS; Fanfair RN; Park BJ; Harris JR
PLoS One; 2013; 8(4):e62213. PubMed ID: 23626792
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of Cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia.
Alemu AS; Kempker RR; Tenna A; Smitson C; Berhe N; Fekade D; Blumberg HM; Aseffa A
PLoS One; 2013; 8(3):e58377. PubMed ID: 23469276
[TBL] [Abstract][Full Text] [Related]
16. Implementation of point-of-care testing and prevalence of cryptococcal antigenaemia among patients with advanced HIV disease in Mumbai, India.
Acharya S; Allam RR; Karanjkar VK; Rathod D; Mahajan R; Deshpande P; Palkar A; Todmal S; Koli S; Dhande S; Dale J; Yeldandi VV; Harshana A; Agarwal R; Upadhyaya S; Nyendak M
BMJ Open; 2023 Jun; 13(6):e070500. PubMed ID: 37349096
[TBL] [Abstract][Full Text] [Related]
17. Hyponatremia as a Predictor of Cryptococcal Meningitis and Death Among Asymptomatic Persons With HIV and Cryptococcal Antigenemia.
Lehman A; Nalintya E; Wele A; Kirumira P; Naluyima R; Namuli T; Turya Musa F; Skipper CP; Meya DB; Boulware DR; Rajasingham R
Open Forum Infect Dis; 2023 Mar; 10(3):ofad156. PubMed ID: 37008569
[TBL] [Abstract][Full Text] [Related]
18. Etiology of meningitis among adults in three quaternary hospitals in Mozambique, 2016-2017: The role of HIV.
Nhantumbo AA; Comé CE; Maholela PI; Munguambe AM; Costa PD; Mott M; Cunha GR; Chambal L; Dias C; Cantarelli VV; Gudo ES
PLoS One; 2022; 17(5):e0267949. PubMed ID: 35544535
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of point of care serum cryptococcal antigen by lateral flow immunoassay for diagnosis of cryptococcosis and cryptococcal meningitis in HIV-positive patients.
Kamble U; Dheeresh KH; Bhosale K; Indu MB; Sharma B; Chowdhary A
Indian J Sex Transm Dis AIDS; 2021; 42(1):14-18. PubMed ID: 34765932
[TBL] [Abstract][Full Text] [Related]
20. Application and evaluation of nucleic acid sequence-based amplification, PCR and cryptococcal antigen test for diagnosis of cryptococcosis.
Wang Y; Yang M; Xia Y; Yan J; Zou J; Zhang D
BMC Infect Dis; 2021 Sep; 21(1):1020. PubMed ID: 34587908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
